LegalCaseDocs.com
shopping cart  
  |     
Search
 

 
New Visitors


 VeriSign Secure Site

 Get Adobe Reader

SEC v IVES HEALTH COMPANY and M. KEITH IVES Click to find out why . . .



Keywords & Phrases
CaseNo: LR-16957, Defendant: Ives Health Company and M. Keith Ives, Plaintiff: SEC, State: OK Oklahoma, UniqueCaseRef: SEC>LR-16957, Ives Health, Ives Health Company, Keith Ives, Criminal Complaint, Exchange, Commission, Distributing, Drug, Fda, According, T-factor, Inventor, Java Project, Health Organization, Ives Health Stock, Public Statements, Investors, Treatment, Human Immunodeficiency Virus, Exchange Act, Charges Keith Ives, Violation, Fda Law, Wire Fraud, Website, T-cell, Hiv-positive Individuals, Jakarta, Indonesia, Company Alleges , ContentID: 120241156

Case Documents
1 2001-04-10 SEC LITIGATION RELEASE
[ see first page and extracted highlights below  ] ItemID: 104249
1 pages
TXT
Total Documents: 1 document , 1 page.    CAUTION.    PLEASE NOTE THAT THIS IS A ONE PAGE CASE.
Price: $ 19.95


IVESLCD01 KGI0001
 
 

 Forgot your password?


1 . SEC LITIGATION RELEASE

EXTRACTED KEY WORDS
IVES HEALTH COMPANY
KEITH IVES
CRIMINAL COMPLAINT
EXCHANGE
COMMISSION
DISTRIBUTING
DRUG
FDA
ACCORDING
T-FACTOR
INVENTOR
JAVA PROJECT
HEALTH ORGANIZATION
IVES HEALTH STOCK
PUBLIC STATEMENTS
INVESTORS
TREATMENT
HUMAN IMMUNODEFICIENCY VIRUS
EXCHANGE ACT
CHARGES KEITH IVES
VIOLATION
FDA LAW
WIRE FRAUD
WEBSITE
T-CELL
HIV-POSITIVE INDIVIDUALS
JAKARTA
INDONESIA
COMPANY ALLEGES
   SECURITIES AND EXCHANGE COMMISSION

   Litigation Release No. 16957 / April 10, 2001

   UNITED STATES v. IVES HEALTH COMPANY AND M. KEITH IVES
   01 Mag 0569 (S.D.N.Y.)

   Keith Ives, the founder and president of an Oklahoma-based vitamin and
   nutritional supplement manufacturer, Ives Health Company, was arrested
   on April 4th for fraudulently advertising and distributing a purported
   drug for AIDS and HIV. The Commission suspended trading in Ives Health
   stock on March 5th because of "questions regarding the accuracy of
   public statements by Ives Health to investors concerning, among other
   things, a product being marketed by Ives Health for treatment of human
   immunodeficiency virus (HIV)." Exchange Act Release No. 44038.

   A criminal complaint, unsealed on April 5th, charges Keith Ives and
   Ives Health Co. with fraudulently distributing an unapproved new drug,
   in violation of FDA law, as well as with wire fraud. According to the
   criminal complaint, Ives Health claimed in a press release on February
   15th, as well as on its website, that "T-Factor" would increase the
   T-cell count of HIV-positive individuals, and had been tested by its
   inventor, "Dr. Robert Slayton-Bedeen," in Jakarta, Indonesia. The
   so-called "Java Project" was conducted in association with the World
   Health Organization, according to the company's claims. The criminal
   complaint against Ives and his company alleges, among other things,
   that T-Factor was never approved by the FDA, that there is no record
   of a "Java Project," and that the World Health Organization is not
   aware of the product, its inventor or any testing.
     _________________________________________________________________

Modified 04/11/2001
SNIPPETS:
  • SECURITIES AND EXCHANGE COMMISSION
  • Keith Ives, the founder and president of an Oklahoma-based vitamin and nutritional supplement
  • The Commission suspended trading in Ives Health stock on March 5th because of "questions
  • Exchange Act Release No. 44038.
  • A criminal complaint, unsealed on April 5th, charges Keith Ives and Ives Health Co. with
  • According to the criminal complaint, Ives Health claimed in a press release on February 15th,
  • The so-called "Java Project" was conducted in association with the World Health Organization,
  • The criminal complaint against Ives and his company alleges, among other things, that
  •    |